TYLER BACHRODT: Open Payments
NPI 1477980449 · SMITHFIELD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,949 in 103 payments from 15 companies in 2025. Trend: 2023 $1,248 · 2024 $1,566 · 2025 $1,949
Food & beverage: $1,949
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $556 |
| Janssen Biotech, Inc. | 17 | $344 |
| Ardelyx, Inc. | 7 | $158 |
| Aimmune Therapeutics, Inc. | 10 | $145 |
| Phathom Pharmaceuticals, Inc. | 10 | $117 |
| GENZYME CORPORATION | 4 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $99 |
| Madrigal Pharmaceuticals | 5 | $97 |
| PFIZER INC. | 4 | $76 |
| Lilly USA, LLC | 3 | $68 |
Products named: TREMFYA, RINVOQ, IBSRELA, ZENPEP, DUPIXENT, LINZESS, VOQUEZNA, CREON.
Industry payments across NC — which companies pay providers there.
